NUMITOR Study: Nummular Headache Iberian Study on the Treatments and Outcomes in Real-World Setting
NCT05475769 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 98
Last updated 2024-02-28
Summary
The NUMITOR study is an analytical observational study with an multicenter ambisective (retrospective and prospective) cohort design.
Conditions
- Headache Disorders, Secondary
- Headache Disorders
- Central Nervous System Diseases
- Brain Diseases
- Neurologic Manifestations
- Nervous System Diseases
- Pain
Interventions
- DRUG
-
Clinical evaluation
Patients will receive treatments under the criteria of the responsible physician and the response to these treatments will be prospectively collected.
Sponsors & Collaborators
-
Hospital Clínico Universitario de Valladolid
lead OTHER
Principal Investigators
-
David García-Azorín, MD, PhD · Hospital Clínico Universitario de Valladolid
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-03-01
- Primary Completion
- 2024-12-31
- Completion
- 2024-12-31
Countries
- Spain
Study Locations
More Related Trials
-
Status Migrainosus - Differentiating Between Responders and Non-responders
NCT03066544 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine
NCT04825678 ·Status: COMPLETED ·Phase: PHASE4
-
An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months
NCT00806546 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Quality of Life in Subjects With Chronic or High-frequency Episodic Migraine and Associated Comorbidities Treated With Erenumab
NCT04114630 ·Status: WITHDRAWN ·Phase: PHASE3
-
The Effect of Sumatriptan and Placebo on Isosorbide-5-mononitrate Induced Headache
NCT02485340 ·Status: COMPLETED ·Phase: NA
-
The Effect of Anti-calcitonin Gene-related Peptide (CGRP) Receptor Antibodies on the Headache Inducing Properties of CGRP and Cilostazol in Migraine Patients
NCT04452929 ·Status: UNKNOWN ·Phase: NA
-
A Study of Lasmiditan (LY573144) Over Four Migraine Attacks
NCT03670810 ·Status: COMPLETED ·Phase: PHASE3
-
Botulinum Toxin Type A Blockade of the Sphenopalatine Ganglion in Treatment-refractory Chronic Cluster Headache
NCT03944876 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy of Erenumab in Chronic Cluster Headache
NCT04970355 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of LY3451838 in Participants With Migraine
NCT04498910 ·Status: COMPLETED ·Phase: PHASE2
-
Post-marketing Clinical Trial of Elexir(Trigeminal Nerve Electrical Stimulator) for the Acute Treatment of Migraine
NCT06170411 ·Status: RECRUITING ·Phase: NA
-
Migraine Attack Treatment Response Molecular and Clinical BiOmarkers (MAMBO) Phase I
NCT06503848 ·Status: RECRUITING
-
The Evolution and Management of Migraine Recurrence Beyond 24 Hours
NCT00754611 ·Status: COMPLETED
-
Eptinezumab in Participants With Episodic Cluster Headache
NCT04688775 ·Status: COMPLETED ·Phase: PHASE3
-
Cluster Headache Treatment With Rimegepant
NCT05264714 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Lasmiditan (LY573144) in a Single Migraine Attack in Japanese Participants With Migraine
NCT03962738 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Intranasal Ketorolac for the Acute Treatment of Migraine
NCT00483717 ·Status: COMPLETED ·Phase: PHASE2
-
Dose-ranging Study of Oral COL-144 in Acute Migraine Treatment
NCT00883051 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of SOM230 s.c. in Cluster Headache
NCT02619617 ·Status: TERMINATED ·Phase: PHASE2
-
Treatment of Episodic Migraine With AURICular Neuromodulation
NCT06623188 ·Status: RECRUITING ·Phase: NA
-
Topiramate and Cerebrovascular Response in Migraineurs
NCT02424318 ·Status: COMPLETED ·Phase: PHASE4
-
Study for Prevent Chronification Migraine Through Prediction of Response to Treatment With Anti-CGRP Antibodies
NCT06459648 ·Status: RECRUITING
-
Hypersensitivity to CGRP as a Predictive Biomarker of Migraine Prevention With Erenumab
NCT04592952 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effect of Sumatriptan and Placebo on Cilostazol Induced Headache
NCT02486276 ·Status: COMPLETED ·Phase: NA
-
Effects of Adding an Oculomotor Therapy Treatment in Patients With Migraine
NCT05842642 ·Status: COMPLETED ·Phase: NA